---
$id: https://graph.org.ai/products/commodity/51241134
$type: Product
source: UNSPSC
code: "51241134"
title: "Pegaptanib sodium"
class: "51241100"
classTitle: "Ophthalmic agents"
family: "51240000"
familyTitle: "Drugs affecting the ears, eye, nose and skin"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Pegaptanib sodium

**UNSPSC Code**: 51241134
**Class**: [Ophthalmic agents](Ophthalmic agents.mdx)
**Family**: [Drugs affecting the ears, eye, nose and skin](../Drugs affecting the ears, eye, nose and skin.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an angiogenesis inhibitor, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 3HP012Q0FH. European Medicines Agency schedules Pegaptanib sodium in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB21226. Pegaptanib sodium generally arises in the molecular formula C15H28N3O6(C2H4O)N(C2H4O)N.28NA. The term 'pegaptanib sodium' is a United States Adopted Name designation. Most nations, for tariff and trade purposes, schedule pegaptanib sodium under HS 39072021 and SITC 57419. Pegaptanib sodium bears US NLM identifiers UMLS ID C0967532 and NCI Concept Code C95230. SMILES: As of Q4 2014, PEGAPTANIB SODIUM remains US FDA's Preferred Term for this commodity.

